Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis.

Samankaltaisia teoksia

• Comparison of disease activity measures for ANCA-associated vasculitis.
  Tekijä: Merkel, P, et al.
  Julkaistu: (2004)
• EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
  Tekijä: Hellmich, B, et al.
  Julkaistu: (2007)
• Use of a computerised system to facilitate evaluation of anti-neutrophil cytoplasm (ANCA Associated) vasculitis (AAV) and other forms of systemic vasculitis
  Tekijä: Luqmani, R, et al.
  Julkaistu: (2017)
• Positive predictive value of anti-neutrophil cytoplasmic antibody (ANCA) testing for ANCA-associated systemic vasculitis (AASV) in a routine clinical setting
  Tekijä: McLaren, J, et al.
  Julkaistu: (2001)
• The UK & Ireland Vasculitis Registry (UKIVAS): Cross-sectional data on the first 2290 Patients with anti-neutrophil cytoplasm (ANCA) associated vasculitis (AAV)
  Tekijä: Luqmani, R, et al.
  Julkaistu: (2017)